First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, ...

Manchester United manager Erik ten Hag was frustrated with his side’s lack of clinical finishing in their goalless draw with ...

Whilst J&J’s Shockwave has a strong grasp on the IVL market, other players are emerging with differentiated technologies.

When surveyed, many physicians said the belief that patients had adequate symptom control was why they didn’t add more meds.

Health tech startup Dandelion Health launched a clinical artificial intelligence marketplace that merges third-party ...

A phase II trial for patients with traumatic brain injury (TBI) will aim to break the impasse of 30 years of failed clinical ...

A drug approved for treating the blood cancer multiple myeloma may offer a safe and effective way to reduce the risk of severe nosebleeds from a rare but devastating bleeding disorder. Hereditary ...

Patients can benefit from clinical trials in gynecologic cancers, and knowing that they can advocate for themselves for ...

KENNETT SQUARE, PA — Powerback Rehabilitation has announced a strategic partnership with PredictionHealth to incorporate ...

To keep up with contemporary demands, healthcare organizations – and the technology they use – need to provide anywhere, anytime access to clinical applications and information. Mobile tools can ...

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vasc ...

Canaccord Genuity analyst John Newman has maintained their bullish stance on ONCY stock, giving a Buy rating yesterday. John Newman has given ...